{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:59Z","timestamp":1793089079954,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To examine the monitoring, management, and outcomes of pituitary tumors in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>A national, prospective, observational, population-based case series study was conducted in all U.K. consultant-led obstetric units over 3 years using the U.K. Obstetric Surveillance System. To evaluate rates of adverse pregnancy outcomes, women with a macroprolactinoma (10 mm or greater) or nonfunctioning pituitary adenoma, diagnosed before or during pregnancy, were compared with two comparison groups: 1) a U.K. Obstetric Surveillance System cohort with singleton (n=2,205) or twin (n=27) pregnancy; and 2) data from the Office of National Statistics (n=2,703,102). Main outcome measures were the incidence, management, and frequency of adverse maternal and offspring outcomes of pituitary tumors in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>There were 71 confirmed cases of pituitary tumors in pregnancy (49 macrolactinoma, 16 nonfunctioning adenomas, three acromegaly, three Cushing's disease). The women with pituitary tumors were 4 years older than comparison women (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). None of the nine women treated with surgery or radiotherapy before pregnancy had symptomatic tumor expansion. This occurred in 6 of 40 women with macroprolactinomas and one of seven nonfunctioning adenomas diagnosed before conception and in three of five women with nonfunctioning adenomas diagnosed in pregnancy. Two women had pituitary apoplexy, both of whom also had symptoms of expansion of tumor or surrounding pituitary tissue. To within the level of accuracy possible, there was no evidence that pituitary tumors were associated with adverse pregnancy outcomes (pregnancy-induced hypertension, preeclampsia, preterm labor, stillbirth). Women with nonfunctioning adenomas were more likely to have cesarean delivery compared with women in a control group (relative risk 2.06, confidence interval 1.26\u20133.36,<jats:italic toggle=\"yes\">P<\/jats:italic>=.035).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION:<\/jats:title><jats:p>The majority of women with macroprolactinomas and nonfunctioning adenomas have good pregnancy outcomes. Nonfunctioning pituitary adenomas occur more commonly in pregnancy than previously thought and can present de novo with symptoms of pituitary expansion in pregnancy.<\/jats:p><\/jats:sec>","DOI":"10.1097\/aog.0000000000001747","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T13:59:24Z","timestamp":1481119164000},"page":"185-194","source":"Crossref","is-referenced-by-count":37,"title":["Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes"],"prefix":"10.1097","volume":"129","author":[{"given":"Kimberley","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandish K.","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"McCance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"suppl A","key":"R3-20230711","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1096-6374(03)00054-6","article-title":"Pituitary tumors and pregnancy","volume":"13","author":"Molitch","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/0003-4819-121-7-199410010-00001","article-title":"Visual loss in pregnant women with pituitary adenomas","volume":"121","author":"Kupersmith","year":"1994","journal-title":"Ann Intern Med"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/014107680309600107","article-title":"Visual field compression by a non-secreting pituitary tumour during pregnancy","volume":"96","author":"Masding","year":"2003","journal-title":"J R Soc Med"},{"key":"R6-20230711","first-page":"107","article-title":"Postoperative diabetes insipidus associated with pituitary apoplexy during pregnancy","volume":"33","author":"Kita","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"key":"R7-20230711","first-page":"393","article-title":"Pituitary apoplexy presenting during pregnancy","volume":"62","author":"de Heide","year":"2004","journal-title":"Neth J Med"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/B:PITU.0000004802.47010.00","article-title":"Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy","volume":"6","author":"Chaiamnuay","year":"2003","journal-title":"Pituitary"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2265.2002.01549.x","article-title":"The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy","volume":"57","author":"Blackhurst","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R10-20230711","first-page":"1164","article-title":"Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide)","volume":"81","author":"Caron","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2011.04180.x","article-title":"Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature","volume":"76","author":"Cheng","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1210\/jc.2009-2331","article-title":"Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women","volume":"95","author":"Caron","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","article-title":"Cushing's syndrome during pregnancy: personal experience and review of the literature","volume":"90","author":"Lindsay","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2307\/3002019","article-title":"An approximate distribution of estimates of variance components","volume":"2","author":"Satterwaite","year":"1946","journal-title":"Biometrics"},{"issue":"suppl 4","key":"R16-20230711","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/humrep\/11.suppl_4.110","article-title":"The outcome of multiple pregnancy","volume":"11","author":"Doyle","year":"1996","journal-title":"Hum Reprod"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jcem-29-12-1533","article-title":"Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis","volume":"29","author":"Goluboff","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0025-6196(12)60946-X","article-title":"The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases","volume":"65","author":"Scheithauer","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.25011\/cim.v35i2.16293","article-title":"Management of prolactinomas during pregnancy\u2014a survey of four Canadian provinces","volume":"35","author":"Almalki","year":"2012","journal-title":"Clin Invest Med"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","article-title":"Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study","volume":"68","author":"Colao","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0890-6238(96)00063-9","article-title":"Pregnancy outcome after treatment with the ergot derivative, cabergoline","volume":"10","author":"Robert","year":"1996","journal-title":"Reprod Toxicol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201701000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T01:48:16Z","timestamp":1718934496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201701000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001747","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}